1. Home
  2. APVO vs NIVF Comparison

APVO vs NIVF Comparison

Compare APVO & NIVF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APVO
  • NIVF
  • Stock Information
  • Founded
  • APVO 2016
  • NIVF 2011
  • Country
  • APVO United States
  • NIVF Hong Kong
  • Employees
  • APVO N/A
  • NIVF N/A
  • Industry
  • APVO Biotechnology: Pharmaceutical Preparations
  • NIVF
  • Sector
  • APVO Health Care
  • NIVF
  • Exchange
  • APVO Nasdaq
  • NIVF NYSE
  • Market Cap
  • APVO 4.4M
  • NIVF 5.2M
  • IPO Year
  • APVO N/A
  • NIVF N/A
  • Fundamental
  • Price
  • APVO $4.50
  • NIVF $0.37
  • Analyst Decision
  • APVO Strong Buy
  • NIVF
  • Analyst Count
  • APVO 1
  • NIVF 0
  • Target Price
  • APVO $296.00
  • NIVF N/A
  • AVG Volume (30 Days)
  • APVO 485.4K
  • NIVF 5.4M
  • Earning Date
  • APVO 11-07-2024
  • NIVF 12-24-2024
  • Dividend Yield
  • APVO N/A
  • NIVF N/A
  • EPS Growth
  • APVO N/A
  • NIVF N/A
  • EPS
  • APVO N/A
  • NIVF N/A
  • Revenue
  • APVO N/A
  • NIVF $5,679,218.00
  • Revenue This Year
  • APVO N/A
  • NIVF N/A
  • Revenue Next Year
  • APVO N/A
  • NIVF N/A
  • P/E Ratio
  • APVO N/A
  • NIVF N/A
  • Revenue Growth
  • APVO N/A
  • NIVF N/A
  • 52 Week Low
  • APVO $3.65
  • NIVF $0.24
  • 52 Week High
  • APVO $399.60
  • NIVF $17.24
  • Technical
  • Relative Strength Index (RSI)
  • APVO 35.34
  • NIVF 40.03
  • Support Level
  • APVO $3.65
  • NIVF $0.24
  • Resistance Level
  • APVO $4.78
  • NIVF $0.43
  • Average True Range (ATR)
  • APVO 1.95
  • NIVF 0.08
  • MACD
  • APVO -0.70
  • NIVF 0.01
  • Stochastic Oscillator
  • APVO 7.55
  • NIVF 28.50

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

About NIVF NEWGENIVF GROUP LIMITED

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

Share on Social Networks: